BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23963825)

  • 21. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
    Renjie W; Haiqian L
    Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.
    Liang L; Nong L; Zhang S; Zhao J; Ti H; Dong Y; Zhang B; Li T
    J Exp Clin Cancer Res; 2014 Jan; 33(1):7. PubMed ID: 24438193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo.
    Dai L; Wang W; Zhang S; Jiang Q; Wang R; Dai L; Cheng L; Yang Y; Wei YQ; Deng HX
    Cell Biol Int; 2012 Aug; 36(8):765-70. PubMed ID: 22574716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.
    Wang H; Li H; Xing X; Zhao C; Luo B
    Arch Virol; 2015 Aug; 160(8):2071-4. PubMed ID: 26008210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
    Chen HH; Huang WT; Yang LW; Lin CW
    Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
    Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
    J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endothelial and vascular smooth muscle cells.
    Zheng X; Li A; Zhao L; Zhou T; Shen Q; Cui Q; Qin X
    Biochem Biophys Res Commun; 2013 Aug; 437(4):625-31. PubMed ID: 23867820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA in extranodal NK/T cell lymphoma, nasal type].
    Ti HJ; Nong L; Wang W; Zhang S; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):610-5. PubMed ID: 22177245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
    Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
    Gualco G; Domeny-Duarte P; Chioato L; Barber G; Natkunam Y; Bacchi CE
    Am J Surg Pathol; 2011 Aug; 35(8):1195-203. PubMed ID: 21716086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.
    Anastasiadou E; Boccellato F; Vincenti S; Rosato P; Bozzoni I; Frati L; Faggioni A; Presutti C; Trivedi P
    Oncogene; 2010 Mar; 29(9):1316-28. PubMed ID: 19966860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
    Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
    Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
    Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
    Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
    Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
    Shinozaki A; Sakatani T; Ushiku T; Hino R; Isogai M; Ishikawa S; Uozaki H; Takada K; Fukayama M
    Cancer Res; 2010 Jun; 70(11):4719-27. PubMed ID: 20484038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
    Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
    Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.
    Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H
    Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.